Assyro AI

FDA Orange Book · active-ingredient family

Proparacaine hydrochloride

Proparacaine hydrochloride is approved as 2 brand and 10 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:OPHTHAINE · NDA 008883

2

Brand (NDA)

10

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · solution/drops

ProductApplicantApplicationTEApproved
OPHTHAINERLDAPOTHECONNDA 008883Approved Prior to Jan 1, 1982
OPHTHETICRLDALLERGANNDA 012583Approved Prior to Jan 1, 1982

Generic (ANDA) products (10)

ProductApplicantApplicationTEApproved
PROPARACAINE HYDROCHLORIDEMICRO LABSANDA 219294ATOct 20, 2025
PROPARACAINE HYDROCHLORIDEMANKIND PHARMAANDA 219136ATMay 21, 2025
PROPARACAINE HYDROCHLORIDESOMERSET THERAPS LLCANDA 215816ATAug 09, 2024
PROPARACAINE HYDROCHLORIDERISINGANDA 040277ATMar 16, 2000
PROPARACAINE HYDROCHLORIDEBAUSCH AND LOMB INCANDA 040074ATSep 29, 1995
KAINAIRPHARMAFAIRANDA 088087Jun 07, 1983
PARACAINEOPTOPICSANDA 087681Aug 05, 1982
ALCAINEALCON LABS INCANDA 080027ATApproved Prior to Jan 1, 1982
PROPARACAINE HYDROCHLORIDESOLA BARNES HINDANDA 084144Approved Prior to Jan 1, 1982
PROPARACAINE HYDROCHLORIDESOLA BARNES HINDANDA 084151Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Proparacaine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.